Madrigal Pharmaceuticals Inc (MDGL) USD0.00010
Sell:$331.41Buy:$332.69
$2.64
(0.80%)
NASDAQ:
0.70%
0.70%Market closed | Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$331.41
Buy:$332.69
Change:$2.64
(0.80%)
$2.64
(0.80%)Market closed | Prices delayed by at least 15 minutes
Sell:$331.41
Buy:$332.69
Change:$2.64
(0.80%)
$2.64
(0.80%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 71 | $313.08 | $22,228.68 | 10,367 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 200 | $314.74 | $62,948.00 | 10,167 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 300 | $320.21 | $96,063.00 | 9,867 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 200 | $323.65 | $64,730.00 | 9,667 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 200 | $324.59 | $64,918.00 | 9,467 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 100 | $326.34 | $32,634.00 | 9,367 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 100 | $327.49 | $32,749.00 | 9,267 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 100 | $329.64 | $32,964.00 | 9,167 |
| 3 March 2025 | Carole HuntsmanChief Level Officer | Sell Regular sell transaction (market) | 563 | $335.00 | $188,605.00 | 8,604 |
| 3 March 2025 | Mardi DierCFO | Sell Tax related | 1,187 | $325.89 | $386,831.43 | 7,688 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 March 2024 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 970,951 | $260.00 | $252,447,162.90 | 2,493,602 |
| 21 March 2024 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 86,741 | $260.00 | $22,552,651.33 | 212,188 |
| 27 February 2025 | James Michael (Jim) DalyIndependent Director | Sell Option/Award related | 14,302 | $347.39 | $4,968,371.78 | 2,682 |
| 3 April 2024 | Rebecca Anne TaubOther Level A | Sell Option/Award related | 18,917 | $245.34 | $4,641,013.55 | 461,088 |
| 3 April 2024 | Paul A FriedmanDirector | Sell Option/Award related | 18,806 | $245.34 | $4,613,822.67 | 187,556 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.